Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Discordance Between FFR and iFR. Which Measurement Is More Important?

In the next days, Dr. Seung Hun and colleagues will publish in J Am Coll Cardiol Intv 2019 a study that answers the title question and also brings peace of mind about the decisions we make based on one of these measurements or the other.

La performance diagnóstica del iFR hace temblar al FFR

This study assessed the physiologic characteristics of discordant lesions between instantaneous wave-free ratio (iFR) and fractional flow reserve (FFR), and their impact on the prognosis at 5 years.

Both iFR and FFR are standard methods for the assessment of the functional significance of coronary artery lesions. However, there is a lack of literature regarding how to manage cases in which the results for these measurements do not match, and regarding the clinical impact of making decisions based on one method over the other.

Researchers evaluated a total of 840 vessels from 596 patients classified in groups according to iFR and FFR: high iFR–high FFR (n = 580), low iFR–high FFR (n = 40), high iFR–low FFR (n = 69), and low iFR–low FFR (n = 128). These patients were compared with a control group.


Read also: Meta-Analysis of Large TAVR Studies on Low-Risk: Evidence is Consistent.


Differences were measured and observed through other methods, such as coronary flow reserve (CFR), index of microcirculatory resistance (IMR), and resistance reserve ratio (RRR), reflecting the vasodilatory capacity of coronary microcirculation.

The follow-up period was 5 years, and researchers registered all-cause death, any infarction, and any revascularization, comparing revascularized patients with those who were deferred.

In the low iFR–high FFR group, all other measurements (CFR, RRR, and IMR) were similar to those of the low iFR–low FFR group. In the high iFR–low FFR group, the other parameters were similar to those of the control group.

Among the 4 groups, when classified by iFR and FFR, CFR and RRR are significantly different, unlike IMR.



Read also: 1000 MitraClips: Results from the World’s Most Experienced Site.


Such discordance between iFR and FFR did not affect the clinical endpoints.

Significant differences in the endpoints were present only upon comparison between the low iFR–low FFR and the high iFR–high FFR groups (p = 0.018).

Conclusion

There were differences in coronary function, especially in the vasodilatory capacity, between patients with iFR and FFR discordance. However, such discordance did not impact clinical results at 5 years.

Original title: Physiologic Characteristics and Clinical Outcomes of Patients With Discordance Between FFR and iFR.

Reference: Seung Hun Lee et al. J Am Coll Cardiol Intv 2019, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...